119 related articles for article (PubMed ID: 30530769)
1. Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors.
Leung DTH; Nguyen T; Oliver EM; Matti J; Alexiadis M; Silke J; Jobling TW; Fuller PJ; Chu S
Mol Cancer Ther; 2019 Feb; 18(2):364-375. PubMed ID: 30530769
[TBL] [Abstract][Full Text] [Related]
2. Targeting XIAP and PPARγ in Granulosa Cell Tumors Alters Metabolic Signaling.
Leung DTH; Rainczuk A; Nguyen T; Stephens A; Silke J; Fuller PJ; Chu S
J Proteome Res; 2019 Apr; 18(4):1691-1702. PubMed ID: 30706710
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor of apoptosis proteins are potential targets for treatment of granulosa cell tumors - implications from studies in KGN.
Bagnjuk K; Kast VJ; Tiefenbacher A; Kaseder M; Yanase T; Burges A; Kunz L; Mayr D; Mayerhofer A
J Ovarian Res; 2019 Aug; 12(1):76. PubMed ID: 31412918
[TBL] [Abstract][Full Text] [Related]
4. Mixtures of persistent organic pollutants increase ovarian granulosa tumor cell line migration and spheroid invasion by upregulating MMP2 expression and activity via IGF1R.
Gogola-Mruk J; Hoffmann-Młodzianowska M; Kamińska K; Ptak A
Toxicology; 2021 Mar; 452():152715. PubMed ID: 33571556
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.
Qiao L; Dai Y; Gu Q; Chan KW; Zou B; Ma J; Wang J; Lan HY; Wong BC
Mol Cancer Ther; 2008 Jul; 7(7):2203-11. PubMed ID: 18645029
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of Granulosa Cell Tumors of the Ovary.
Jamieson S; Fuller PJ
Int J Gynecol Cancer; 2015 Sep; 25(7):1224-31. PubMed ID: 26067856
[TBL] [Abstract][Full Text] [Related]
7. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
Chu S; Nishi Y; Yanase T; Nawata H; Fuller PJ
Mol Endocrinol; 2004 Aug; 18(8):1919-28. PubMed ID: 15155785
[TBL] [Abstract][Full Text] [Related]
8. Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.
Bilandzic M; Chu S; Wang Y; Tan HL; Fuller PJ; Findlay JK; Stenvers KL
Mol Endocrinol; 2013 Mar; 27(3):466-79. PubMed ID: 23322721
[TBL] [Abstract][Full Text] [Related]
9. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
10. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Yokoyama Y; Xin B; Shigeto T; Mizunuma H
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
[TBL] [Abstract][Full Text] [Related]
11. Persistent endocrine-disrupting chemicals found in human follicular fluid stimulate IGF1 secretion by adult ovarian granulosa cell tumor spheroids and thereby increase proliferation of non-cancer ovarian granulosa cells.
Gogola J; Hoffmann M; Ptak A
Toxicol In Vitro; 2020 Jun; 65():104769. PubMed ID: 31923581
[TBL] [Abstract][Full Text] [Related]
12. Molecular manipulation of keratin 8/18 intermediate filaments: modulators of FAS-mediated death signaling in human ovarian granulosa tumor cells.
Trisdale SK; Schwab NM; Hou X; Davis JS; Townson DH
J Ovarian Res; 2016 Feb; 9():8. PubMed ID: 26911253
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
Yang YC; Tsao YP; Ho TC; Choung IP
Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways.
Wang C; Lv X; Jiang C; Cordes CM; Fu L; Lele SM; Davis JS
PLoS One; 2012; 7(11):e48299. PubMed ID: 23155381
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell lines.
Jamieson S; Fuller PJ
Horm Cancer; 2013 Oct; 4(5):277-92. PubMed ID: 23674259
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition by bortezomib decreases proliferation and increases apoptosis in ovarian granulosa cell tumors.
Chu S; Alexiadis M; Fuller PJ
Reprod Sci; 2009 Apr; 16(4):397-407. PubMed ID: 19087975
[TBL] [Abstract][Full Text] [Related]
17. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
Qiao L; Dai Y; Gu Q; Chan KW; Ma J; Lan HY; Zou B; Rocken C; Ebert MP; Wong BC
Cancer Lett; 2008 Sep; 268(2):260-71. PubMed ID: 18477501
[TBL] [Abstract][Full Text] [Related]
18. YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.
Fu D; Lv X; Hua G; He C; Dong J; Lele SM; Li DW; Zhai Q; Davis JS; Wang C
Endocr Relat Cancer; 2014 Apr; 21(2):297-310. PubMed ID: 24389730
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor profiling of ovarian granulosa cell tumors.
Alexiadis M; Eriksson N; Jamieson S; Davis M; Drummond AE; Chu S; Clyne CD; Muscat GE; Fuller PJ
Horm Cancer; 2011 Jun; 2(3):157-69. PubMed ID: 21761343
[TBL] [Abstract][Full Text] [Related]
20. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
